Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Barrett Esophagus 1Advanced Non-small Cell Lung Cancer 1

Interventions

Endoscopy, Digestive System 7Endoscopy 7Esomeprazole 6Biopsy 5Radiofrequency Ablation 4Omeprazole 4Specimen Handling 3Gastroscopy 3Aspirin 3YF 476 2Proflavine 2Photochemotherapy 2Microscopy, Confocal 2Metformin 2Endoscopic Mucosal Resection 2Endoscopes 2Cryosurgery 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1linaclotide 1chlorhexidine gluconate 1candesartan cilexetil 1candesartan 1Ursodeoxycholic Acid 1Tomography, Optical Coherence 1Sunitinib 1Standard of Care 1Narrow Band Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Barrett Esophagus × rofecoxib × Clear all
NCT00637988 2011-01-21

Barrett's Esophagus - 315 - 3 Way Cross Over

AstraZeneca

Phase 4 Completed
32 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡